Cholesterol Lowering Effect of Lactobacillus plantarum Isolated from Human Feces

  • Ha Chul-Gyu (Department of Biochemistry and Molecular Biology, Hanyang University) ;
  • Cho Jin-Kook (Department of Dairy Science and Gyonggi-do Regional Research Center, Hankyong National University) ;
  • Lee Chi-Ho (Department of Food Science and Biotechnology of Animal Resources, Konkuk University) ;
  • Chai Young-Gyu (Department of Biochemistry and Molecular Biology, Hanyang University) ;
  • Ha Young-Ae (Department of Occupational Medicine, Dong-Kang General Hospital) ;
  • Shin Shang-Hun (Department of Radiology, University of Ulsan College of Medicine, Ulsan University Hospital)
  • Published : 2006.08.01


The purpose of this study was to isolate probiotic lactic acid bacteria (LAB) that produce bile salt hydrolase (BSH), and to evaluate its effects on serum cholesterol level. One-hundred-twenty bacterial colonies were initially isolated from human feces, and five strains were selected after screening based on their resistance to acids, tolerance against bile salts, and inhibitory activity on Escherichia coli. The Lactobacillus plantarum strain with the highest level of BSH activity was identified using 16S rRNA sequences, and was named L. plantarum CK 102. L. plantarum CK 102 at a level of 1.36$\times$10$^8$cfu/ml survived in pH 2 buffer for 6 h and exhibited excellent tolerance for bile salt. Coculturing the strain with E. coli in MRS broth resulted in strong inhibition against growth of E. coli at 18 h. Furthermore, the potential effect of CK 102 on serum cholesterol level was evaluated in rats. Thirty-two rats [Sprague-Dawley (SD) male, 129$\pm$l g, 5 weeks old] were divided into four groups of eight each. For six weeks, Group 1 was fed a normal diet (negative control); Group 2 was fed a cholesterol-enriched diet (positive control); Group 3 was fed a cholesterol-enriched diet plus L. plantarum CK 102 at 1.0$\times$10$^7$cfu/ml; and Group 4 was fed a cholesterol-enriched diet plus L. plantarum CK 102 at 5.0$\times$10$^7$cfu/ml. Blood samples were collected, serum lipids were analyzed, and weights of the organs were measured. Total blood cholesterol level, triglyceride, LDL-cholesterol, and free-cholesterol values were lower in rats that were fed 1. plantarum CK 102 than in those not fed L. plantarum CK 102. This cholesterol lowering effect implies that L. plantarum CK 102 could be utilized as an additive for health-assistance foods. In conclusion, these results suggest that the 1. plantarum CK 102 isolated could be used commercially as a probiotic.



  1. Aboderin, I., A. Kalache, and Y. Ben-Shlomo. 2002. Life course perspectives on coronary heart disease, stroke and diabetes: Key issues and implications for policy and research. World Health Organization, Geneva
  2. Alkain, A. S., S. Gone, and S. Duzel. 1997. Influence of yogurt and acidophilus yogurt on serum cholesterol levels in mice. J. Dairy Sci. 80: 2721-2725
  3. Anderson, K. M., W. P. Castelli, and D. Levy. 1987. Cholesterol and mortality. 30 years of follow-up from the Framingham study. J. Am. Med. Assoc. 257: 2176
  4. Been, A. and V. Prasad. 1997. Effect of yogurt and bifidus yogurt fortified with skim milk powder, condensed whey and lactose-hydrolyzed condensed shay on serum cholesterol and triacylglycerollevels in rats. J. Dairy Res. 64: 453-457
  5. Committee on Medical Aspects of Food Policy. 1984. Diet and cardiovascular disease: Report of the panel on diet in relation to cardiovascular disease. Department of Heart and Social Subjects, Her Majesty's Stationary Office, London (Reports on Health and Social Subjects. 28: 1-32)
  6. Erkelens, D. W., M. G A. Baggen, J. J. Van Doormeal, M. Kettner, J. C. Koningsberger, and M. J. T. M. Mol. 1998. Clinical experience with simvastin compared with cholestyramine. Drugs 39(SuppI.): 87-90
  7. Frick, M. H., O. Elo, K. Haapa, O. P. Heinonen, P. Heinsalmi, P. Helo, J. K. Huttunen, P. Kaitaniemi, P. Koskinen, and V. Manninen. 1987. Helsinki heart study: Primary-prevention trial with gemfibribrozil in middle-aged men with dyslipidemia. Safety oftreatrnent, changes in risk factors, and incidence of coronary heart disease. N. Engl. J. Med. 317: 1237-1245
  8. Friedewald, W. T., K. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502
  9. Gill, H. S. and F. Guarner. 2004. Probiotics and human health: A clinical perspective. Postgrad. Med. J. 80: 516-526
  10. Gilliland, S. E., C. R. Nelson, and C. Maxwell. 1985. Assimilation of cholesterol by Lactobacillus acidophilus. Appl. Environ. Microbiol. 49: 377-381
  11. Greenwald, C. G. 1991. Overview of fat and cholesterol reduction technologies, pp. 21-34. In C. Haberstroh and C. E. Morris (eds.), Fat and Cholesterol Reduced Foods. Gulf Publishing, London
  12. Han, S. Y., C.-S. Huh, Y.-T. Ahn, K.-S. Lim, Y.-J. Baek, and D.-H. Kim. 2005. Hepatoprotective effect of lactic acid bacteria. J. Microbiol. Biotechnol. 15: 887-890
  13. Henkges, D. J. (ed.) 1983. Biotransformation of bile acids and cholesterol by the intestinal microtlora. In: Human Intestinal Microflora in Health and Disease. Academic Press Inc., New York
  14. Hoverstad, T., T. Bohmer, and O. Fausa. 1982. Absorption of short-chain fatty acids from the human colon measured by the $^{14}CO_2$-breath test. Scand. J. Gastroenterol. 17: 373-378
  15. Hylemon, P. B. and T. L. Glass. 1983. Biotransformation of bile acids and cholesterol by the intestinal microtlora, pp. 189-213. In D. J. Hentges (ed.), Human Intestinal Microflora in Health and Disease. Academic Press Inc., New York
  16. Jones, M. L., H. Chen, W. Ouyang, T. Merz, and S. Parkash. 2004. Microencapsulated genetically engineered Lactobacillus plantarum 80(pCBH 1) for bile acid deconjugation and its implication in lowering cholesterol. J. Biomed. Biotechnol. 1: 61-69
  17. Kim, S. J. 2005. Antimicrobial activities oflactic acid bacteria isolated from Mul-Kimchi. Kor. J. Food Preserv. 12: 263-266
  18. Law, M. R., N. J. Wald, T. Wu, Q. Hackshaw, and A. Bailey. 1994. Systemic underestimation of association between serum cholesterol concentration and ischemic heart disease in observational studies: Data from BUPA study. Br. Med. J. 308: 363-366
  19. Lee, H. Y., J.-H. Park, S.-H. Seok, S.-A. Cho, M.-W. Baek, D.-J. Kim, Y.-H. Lee, and J.-H. Park. 2004. Dietary intake of various lactic acid bacteria suppresses type 2 helper T cell production in antigen-primed mice splenocyte. J. Microbiol. Biotechnol. 14: 167-170
  20. Lee, J. Y., K. Y. Hwang, K. Kim, and S. I. Sung. 2002. Isolation and identification of lactic acid bacteria inhibiting gastro-intestinal pathogenic bacteria of domestic animal. Kor. J. Microbiol. Biotechnol. 30: 129-134
  21. Lewis, R. and S. Gorbach. 1972. Modification of bile acid by intestinal bacteria. Arch. Int. Med. 130: 545-549
  22. Loffier, F. E., Q. Sun, J. Li, and J. Tiedje. 2000. 16S rRNA gene-base detection of tetrachoroethane-dechlorinating desulfuromonase and dehaloccoides species. Appl. Environ. Microbiol. 66: 1369-1374
  23. Mabuchi, H. 1999. Primary and secondary prevention of atherosclerotic disease by lipid-lowering therapies. Nippon Rinsho 57: 2807-2814
  24. Mann, G. V. and A. Spoerry. 1974. Studies of a surfactant and cholesterolemia in the Massai. Am. J. Clin. Nutr. 27: 464-469
  25. Marek, N., H. L. Johansson, D. Z. Downar, and H. Bukowsks. 2002. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am. J. Clin. Nutr. 76: 1249-1255
  26. McDonald, L. C., H. P. Fleming, and H. M. Hassan. 1990. Acid tolerance of Leuconostoc mesenteroides and Lactobacillus casei. Appl. Environ. Microbiol. 53: 2124-2128
  27. Naidu, A. S., W. R. Bidlack, and R. A. Clemens. 1999. Probiotic spectra of lactic acid bacteria (LAB). Crit. Rev. Food Sci. Nutr. 39: 123-126
  28. Pereira, D. I. and G. R. Gibson. 2002. Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit. Rev. Biochem. Mol. Biol. 37: 259-281
  29. Rao, D. R., C. B. Chawan, and S. R. Pulusani. 1981. Influence of milk and thermophilus milk on plasma cholesterol levels and hepatic cholesterogenesis in rats. J. Food Sci. 46: 1339-1341
  30. Rodas, B. Z., S. E. Gilliland, and C. V. Maxwell. 1996. Hypocholesterolemic action of Lactobacillus acidophilus ATCC43121 and calcium in swine with hypercholesterolemia induced by diet. J. Dairy Sci. 79: 2121-2128
  31. Ross, R. 1993. The pathogenesis of atherosclerosis: A perspective for 1990s. Nature 362: 801-809
  32. Sanders, T. A. 1999. Food production of probiotic bacteria to modulate human health. J. Nutr. 130(SuppI.): 384s390s
  33. Seo, M.-J., J.-N. Kim, E.-A. Cho, H. Park, H.-J. Choi, and Y.-R. Pyun. 2005. Purification and characterization of a novel extracellular alkaline phytase from Aeromonas sp. J. Microbiol. Biotechnol. 15: 745-748
  34. Slalter, J., M. Chaplin, J. Dickerson, and F. Davis. 1996. Bile acids and health: Is fiber the answer? Nutr. Food Sci. 6: 29-33
  35. Sneath, P. H. A., et al. (eds.). 1986. Bergey's Manual of Systematic Bacteriology. vol. 2. Williams and Wilkins. Baltimore
  36. St-Onge, M. P., E. R. Farnworth, and P. J. Jones. 2000. Consumption of fermented and nonfermented dairy products: Effects on cholesterol concentrations and metabolism. Am. J. Clin. Nutr. 71: 674-681
  37. Suckling, K. E., G. M. Benson, B. Bond, A. Gee, A. Glen, C. Haynes, and B. Jackson. 1991. Cholesterol lowering and bile acid excretion in the hamster with cholestyramine treatment. Atherosclerosis 89: 183 -190
  38. Tannock, G. W., M. P. Dashkevicz, and S. D. Feighner. 1989. Lactobacilli and bile salt hydrolase in the murine intestinal tract. Appl. Environ. Microbiol. 55: 1848-1851
  39. Taranto, M. P., F. Sesma, A. P. Ruiz Holbano, and G. F. Valdez. 1997. Bile salt hydrolase plays a key role on cholesterol removal by Lactobacillus reuteri. Biotechnol. Lett. 9: 245-247
  40. Vlahcevic, Z. R., D. M. Heuman, and P. B. Hylemon. 1990. Physiology and pathophysiology of enterohepatic circulation of bile acids, pp. 341-377. In D. Zakin and T. D. Boyer (eds.), Hepatology: A Testbook of Liver Disease, vol. I. W. E. Saunders Co., Philadelphia
  41. Wolever, T. M., J. Fernandes, and A. V. Rao. 1996. Serum acetate: Propionate ratio is related to serum cholesterol in men but not women. J. Nutr. 126: 2790-2797
  42. Wolever, T. M., P. Spadafora, and H. Eshuis. 1991. Interaction between colonic acetate and propionate in humans. Am. J. Clin. Nutr. 53: 681-687
  43. Yamamoto, A., H. Horibe, H. Mabuchi, T. Kita, Y. Matsuzawa, Y. Saito, N. Nakaya, T. Fujioka, H. Tenba, A. Kawaguchi, H. Nakamura, and Y. Goto. 1999. Analysis of serum lipid levels in Japanese men and women according to body mass index. Increase in risk of atherosclerosis in postmenopausal women. Research Group on Serum Lipid Survey 1990 in Japan. Atherosclerosis 143: 55-73
  44. Yi, J. H., H.-K. lang, S.-J. Lee, K.-E. Lee, and S.-G. Choi. 2004. Purification and properties of chitosanase from chitinolytic $\beta$-proteobacterium KNU3. J. Microbiol. Biotechnol. 14: 337-343
  45. Young, J. 1998. European market developments in probiotic and probiotic-containing food stuffs. Br. J. Nutr. 80: S231-S233